Display options
Cite
Meidani M, Rezaei F, Maracy MR, et al. Prevalence, severity, and related factors of anemia in HIV/AIDS patients. J Res Med Sci. 2012;17(2):138-42
Meidani, M., Rezaei, F., Maracy, M. R., Avijgan, M., & Tayeri, K. (2012). Prevalence, severity, and related factors of anemia in HIV/AIDS patients. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 17(2), 138-42.
Meidani, Mohsen, et al. "Prevalence, severity, and related factors of anemia in HIV/AIDS patients." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 17,2 (2012): 138-42.
Meidani M, Rezaei F, Maracy MR, Avijgan M, Tayeri K. Prevalence, severity, and related factors of anemia in HIV/AIDS patients. J Res Med Sci. 2012 Feb;17(2):138-42. PMID: 23264786; PMCID: PMC3525030.
Copy Download .nbib Format: NLM
Share it on

J Res Med Sci. 2012 Feb;17(2):138-42.

Prevalence, severity, and related factors of anemia in HIV/AIDS patients.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Mohsen Meidani, Farshid Rezaei, Mohammad Reza Maracy, Majid Avijgan, Katayoun Tayeri

Affiliations

  1. Assistant Profeessor, Infectious Disease and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.

PMID: 23264786 PMCID: PMC3525030

Abstract

OBJECTIVE: The prevalence of anemia in HIV infected patients has not been well characterized in Iran. This study aimed to describe the prevalence of anemia and related factors in HIV positive patients.

MATERIALS AND METHODS: In a cross-sectional study, anemia prevalence and risk factors of 212 HIV positive patients were assessed, at the behavioral disease consulting center in Isfahan. The relationship between anemia, demographic variables, and clinical histories were analyzed. Mild to moderate anemia was defined as hemoglobin 8-13 g/dL for men and 8-12 g/dL for women. Severe anemia was defined as hemoglobin, 8 g/dL.

RESULTS: A total of 212 HIV positive patients with a mean±SD age of 36.1 ± 9.1 years were assessed. We found that hemoglobin levels were between 4.7 and 16.5 gr/dL. In this study, the overall prevalence of anemia was 71%, with the majority of patients having mild to moderate anemia. Mild to moderate anemia and severe anemia occurred in 67% and 4% of patients, respectively. The mean absolute CD4 count was 348 ± 267.8 cells/cubic mm. Sixty one of 212 patients were at late stage of HIV infection (males=51 and female=10). Of the 212 HIV positive patients enrolled, 17 (8%) had a positive history of tuberculosis. We found a strong association between anemia and death.

CONCLUSION: Normocytic anemia with decreased reticulocyte count was the most common type of anemia in overall. Prevalence of anemia in this study is relatively higher than other similar studies. Such a high prevalence of anemia needs close monitoring of patients on a zidovudine-based regimen. Better screening for anemia and infectious diseases, and modified harm reduction strategy (HRS) for injection drug users are primary needs in HIV seropositive patients.

Keywords: AIDS; HIV positive; anemia

References

  1. J Acquir Immune Defic Syndr. 2002 Jan 1;29(1):54-7 - PubMed
  2. N Engl J Med. 1987 Jul 23;317(4):192-7 - PubMed
  3. Afr Health Sci. 2011 Mar;11(1):2-15 - PubMed
  4. Clin Infect Dis. 2004 May 15;38(10):1454-63 - PubMed
  5. Ann Hematol. 1997 Nov-Dec;75(5-6):179-87 - PubMed
  6. Indian J Med Res. 2010 Oct;132:386-9 - PubMed
  7. Int J STD AIDS. 2009 Jul;20(7):489-92 - PubMed
  8. J Acquir Immune Defic Syndr (1988). 1994 Mar;7(3):287-95 - PubMed
  9. J Acquir Immune Defic Syndr. 2005 Oct 1;40(2):198-201 - PubMed
  10. Br J Haematol. 1987 Jun;66(2):251-6 - PubMed
  11. Blood. 1998 Mar 1;91(5):1479-95 - PubMed
  12. J Acquir Immune Defic Syndr. 2004 Oct 1;37(2):1245-52 - PubMed
  13. Clin Infect Dis. 2002 Jan 15;34(2):260-6 - PubMed
  14. J Int AIDS Soc. 2010 Nov 03;13:42 - PubMed
  15. Arch Intern Med. 1991 May;151(5):981-6 - PubMed
  16. Arch Iran Med. 2009 Mar;12(2):145-50 - PubMed
  17. N Engl J Med. 1990 Apr 5;322(14):941-9 - PubMed
  18. AIDS Read. 2004 Jun;14(6):305-10, 313-5 - PubMed
  19. Antivir Ther. 2006;11(6):741-9 - PubMed
  20. AIDS. 2008 Jan 2;22(1):67-74 - PubMed
  21. Curr Med Res Opin. 2007 Feb;23(2):343-55 - PubMed
  22. BMC Infect Dis. 2008 Apr 22;8:52 - PubMed
  23. Am J Hematol. 2002 Jun;70(2):174-6 - PubMed
  24. Blood. 1998 Jan 1;91(1):301-8 - PubMed
  25. Curr Opin Hematol. 1999 Mar;6(2):89-93 - PubMed
  26. Am J Med. 2004 Apr 5;116 Suppl 7A:27S-43S - PubMed
  27. Bull Soc Pathol Exot. 2003 May;96(2):123-7 - PubMed
  28. Transfusion. 2004 Jun;44(6):826-32 - PubMed
  29. J Acquir Immune Defic Syndr. 2001 Jan 1;26(1):28-35 - PubMed
  30. BMC Res Notes. 2010 Aug 20;3:230 - PubMed

Publication Types